Publications by authors named "Steven Zeldenrust"

Claim this Profile
C
Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis.
Eli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, Surbhi Sidana, Ronald S Go, Steven Zeldenrust

Leukemia· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis.
Eli Muchtar, Morie A Gertz, Taxiarchis V Kourelis, Surbhi Sidana, Ronald S Go, Steven Zeldenrust

Leukemia· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis.
Eli Muchtar, Angela Dispenzieri, Dragan Jevremovic, David Dingli, Francis K Buadi, Steven Zeldenrust

Amyloid· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis.
Angela Dispenzieri, Bonnie Arendt, Surendra Dasari, Mindy Kohlhagen, Taxiarchis Kourelis, Steven Zeldenrust

Blood Cancer J· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria.
Eli Muchtar, Angela Dispenzieri, Nelson Leung, Martha Q Lacy, Francis K Buadi, Steven Zeldenrust

Amyloid· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy.
Bharat Nandakumar, Shaji K Kumar, Angela Dispenzieri, Francis K Buadi, David Dingli, Steven Zeldenrust

Clin Lymphoma Myeloma Leuk· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis.
Rahma Warsame, Betsy LaPlant, Shaji K Kumar, Kristina Laumann, Gabriela Perez Burbano, Steven Zeldenrust

Blood Cancer J· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma.
Patrick W Mellors, Moritz Binder, Francis K Buadi, Martha Q Lacy, Morie A Gertz, Steven R Zeldenrust

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year survivors in AL amyloidosis: characteristics and treatment pattern.
Eli Muchtar, Morie A Gertz, Martha Q Lacy, Ronald S Go, Francis K Buadi, Steven Zeldenrust

Br J Haematol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy.
Marcella A Tschautscher, Dragan Jevremovic, Vincent Rajkumar, Angela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust

Am J Hematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of acquired del(17p) in multiple myeloma.
Arjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, Rhett P Ketterling, Prashant Kapoor, Steven R Zeldenrust

Blood Adv· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma.
Gaurav Goyal, S Vincent Rajkumar, Martha Q Lacy, Morie A Gertz, Francis K Buadi, Steven R Zeldenrust

Leukemia· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substratification of patients with newly diagnosed standard-risk multiple myeloma.
Moritz Binder, S Vincent Rajkumar, Rhett P Ketterling, Angela Dispenzieri, Martha Q Lacy, Steven R Zeldenrust

Br J Haematol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma.
Moritz Binder, S Vincent Rajkumar, Martha Q Lacy, Morie A Gertz, Francis K Buadi, Steven R Zeldenrust

Am J Hematol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of staging systems in AL amyloidosis.
Eli Muchtar, Terry M Therneau, Dirk R Larson, Morie A Gertz, Martha Q Lacy, Steven Zeldenrust

Leukemia· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing.
Eli Muchtar, Morie A Gertz, Robert A Kyle, Martha Q Lacy, David Dingli, Steven Zeldenrust

Mayo Clin Proc· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of multiple myeloma with de novo del(17p).
Arjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, Rhett P Ketterling, Prashant Kapoor, Steven R Zeldenrust

Blood Cancer J· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio.
Eli Muchtar, Angela Dispenzieri, Nelson Leung, Martha Q Lacy, Francis K Buadi, Steven R Zeldenrust

Leukemia· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome.
Ashley R Paquin, Shaji K Kumar, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Steven R Zeldenrust

Blood Cancer J· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria.
Eli Muchtar, Angela Dispenzieri, Nelson Leung, Martha Q Lacy, Francis K Buadi, Steven Zeldenrust

Leukemia· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma.
Ankit Kansagra, Wilson I Gonsalves, Morie A Gertz, Francis K Buadi, David Dingli, Steven R Zeldenrust

Biol Blood Marrow Transplant· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance.
Arjun Lakshman, Shilpa Paul, S Vincent Rajkumar, Rhett P Ketterling, Patricia T Greipp, Steven R Zeldenrust

Leukemia· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.
Patrick W Mellors, Moritz Binder, Francis K Buadi, Martha Q Lacy, Morie A Gertz, Steven R Zeldenrust

Am J Hematol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis.
Surbhi Sidana, Nidhi Tandon, Angela Dispenzieri, Morie A Gertz, David Dingli, Steven R Zeldenrust

Leukemia· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.
Arjun Lakshman, S Vincent Rajkumar, Francis K Buadi, Moritz Binder, Morie A Gertz, Steven R Zeldenrust

Blood Cancer J· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis